SPONSOR
GlaxoSmithKline
Total Trials
15
Recruiting
15
Phases
Phase 1, Phase 3, Phase 2, Phase 1, Phase 2
Conditions studied: Systemic Lupus ErythematosusGastrointestinal NeoplasmsGastrointestinal Stromal NeoplasmsMultiple MyelomaNeoplasms, EndometrialAlzheimer's DiseaseTumours, GynecologicalHerpes ZosterSalmonella InfectionsConnective Tissue Diseases
GlaxoSmithKline is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Systemic Lupus Erythematosus, Gastrointestinal Neoplasms, Gastrointestinal Stromal Neoplasms, Multiple Myeloma.
The trial portfolio spans Phase 1, Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — GlaxoSmithKline
How many clinical trials has GlaxoSmithKline sponsored?
ClinicalMetric currently tracks 15 clinical trials sponsored by GlaxoSmithKline, of which 15 are actively recruiting participants. These trials cover conditions including Systemic Lupus Erythematosus, Gastrointestinal Neoplasms, Gastrointestinal Stromal Neoplasms. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does GlaxoSmithKline research focus on?
GlaxoSmithKline clinical trials span Systemic Lupus Erythematosus, Gastrointestinal Neoplasms, Gastrointestinal Stromal Neoplasms, Multiple Myeloma, Neoplasms, Endometrial, and additional conditions. The research pipeline includes Phase 1, Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a GlaxoSmithKline clinical trial?
To participate in a GlaxoSmithKline trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all GlaxoSmithKline trials with current recruitment status updated daily.
Clinical Trials by GlaxoSmithKline
NCT06576271 Phase 1
Recruiting
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
Systemic Lupus Erythematosus
NCT07371468 Phase 1
Recruiting
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Systemic Lupus Erythematosus
NCT07218926 Phase 3
Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Gastrointestinal Neoplasms
NCT07585266 Phase 3
Recruiting
A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
Gastrointestinal Stromal Neoplasms
NCT07227311 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Multiple Myeloma
NCT07286331 Phase 3
Recruiting
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
Neoplasms, Endometrial
NCT07105709 Phase 2
Recruiting
Open-label Extension Study in Participants With Early Alzheimer's Disease
Alzheimer's Disease
NCT06796907 Phase 1, Phase 2
Recruiting
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Tumours, Gynecological
NCT04006808 Phase 1, Phase 2
Recruiting
A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant
Herpes Zoster
NCT07286370 Phase 2
Recruiting
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants
Salmonella Infections
NCT07689201 Phase 2
Recruiting
A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib
Gastrointestinal Neoplasms
NCT06716606 Phase 3
Recruiting
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Connective Tissue Diseases
NCT07406334 Phase 1
Recruiting
A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose
Pneumonia, Bacterial
NCT04641247 Phase 2
Recruiting
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Ovarian Neoplasms
NCT07085702 Phase 1
Recruiting
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults
Streptococcal Infections
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology